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A Cell paper by Montel-Hagen et al. 
(2008) published last year addresses the 
comparative physiology of ascorbate 
recycling in erythrocytes (Montel-Hagen 
et al., 2008). The authors claim in this 
paper that GLUT1-mediated glucose 
transport decreases whereas GLUT1-
mediated dehydroascorbate (DHA) 
transport increases during erythropoi-
esis despite markedly enhanced GLUT1 
expression.
To support these claims, the authors 
measured the uptake of the phospho-
rylatable analog of glucose, 2-deoxy-
D-glucose (2DG), at different stages 
of erythropoiesis in CD34+ human 
hematopoietic progenitor cells stimu-
lated to differentiate by erythropoietin. 
They observed that the ratio of GLUT1 
mRNA to GAPDH mRNA increased over 
12 days of differentiation by 1000-fold; 
large increases in GLUT1 expression 
were also observed by immunoblot 
analysis. A 4-fold decrease in the rate of 
labeled 2DG accumulation was observed 
between day 0 and day 8, whereas with 
DHA uptake (also transported via GLUT1), 
there is approximately a 3-fold increase 
in uptake between day 0 and day 8.
These apparent differences are 
ascribed to a large increase in stoma-
tin expression during the red blood cell 
maturation process, which could lead to 
sequestration of GLUT1 within lipid rafts 
causing inhibition of glucose transport. 
In support of this hypothesis, the authors 
showed that 2DG uptake in erythrocytes 
from two patients with stomatin defi-
ciency was increased by 50%, whereas 
DHA uptake was decreased by 40%.
Unfortunately, interpretation of these 
data may be obscured by the method 
used to monitor 2DG uptake. The authors 
monitored 2DG uptake in CD34+ cells at 
room temperature for 30 s at a concen-
tration of 0.5 µM. Uptake of 2DG and DHA 
in control erythrocytes and in erythro-
cytes from patients was measured over 
incubation times of 10 min (Figure 5C in 
the Cell paper). At these concentrations 200 Cell 137, April 17, 2009 ©2009 Elsevier and temperatures, sugar equilibration in 
human erythrocytes occurs within 1–2 
s (Carruthers, 1990; Lowe and Walms-
ley, 1986). It is therefore difficult to see 
how a difference in transport in human 
erythrocytes can be ascertained by this 
methodology. Rather, these measure-
ments report the cellular 2DG space, 
which comprises cell water (equilibrated 
in 1–2 s) and a metabolic sink (ongoing 
over 10 min).
The authors indicated that they 
observed competitive inhibition of 2DG 
uptake with 5 mM glucose. This will 
indeed reduce uptake of label via the 
GLUT1 glucose transporter but also will 
reduce uptake of label into the hexose 
phosphate pool. They also state that 
uptake of the nonmetabolizable sugar 
3-O methylglucose is inhibited by 5 mM 
glucose over a 60 s time period. How-
ever, this information is not germane to 
the comparative data regarding 2DG 
uptake. We think that all of the differ-
ences in radiolabeled 2DG uptake must 
be due to incorporation of the sugar 
into the hexose phosphate pool. To the 
extent that there are differences, these 
can only reflect changes in the activities 
of the glycolytic enzymes, hexokinase, 
and perhaps also glucose-6-phosphate 
dehydrogenase, rather than GLUT1 
activity. Consistent with this notion is 
the 90- to 150-fold downregulation of 
hexokinase that occurs during erythro-
blast maturation in humans (Shinohara 
et al., 1985) and rabbits (Magnani et 
al., 1984), which may result from ATP- 
and ubiquitin-dependent proteolysis of 
hexokinase (Magnani et al., 1986).
It is also probable that the rate of 
DHA transport is underestimated. 
The reported lack of inhibition of DHA 
uptake by glucose in red blood cells is 
inconsistent with previous findings in 
human erythrocytes (Mann and Newton, 
1975), oocytes heterologously express-
ing GLUT1, GLUT3, or GLUT4 (Rumsey 
et al., 1997, 2000), and rat adipocytes 
expressing GLUT1 and GLUT4 (Rumsey Inc.et al., 2000). This suggests that DHA 
uptake was measured at time points 
where intracellular recycling to ascor-
bate, rather than partially inhibited DHA 
transport, is rate limiting for intracellular 
accumulation of radiolabel.
We do not question the reproducibility 
of Montel-Hagen’s data, only the interpre-
tation. Although the capacity for and rate 
of sugar transport in human erythrocytes 
is large, the use of tracer concentrations 
of 2DG means that 2DG phosphorylation 
by intracellular hexokinase will consti-
tute a large component of net radiolabel 
uptake even at the earliest time points 
recorded at low temperatures. Thus, lin-
earity of 0.5 µM 2DG uptake by human 
red blood cells at early time points cannot 
be ascribed solely to transport. Rather, it 
is ambiguously affected by intracellular 
metabolism. At later time points (>5–10 
s), even at or above 4°C, when cytoso-
lic free sugar has fully equilibrated with 
the extracellular sugar pool, net uptake 
is solely dependent on the rate of 2DG 
metabolism. The only way to unambigu-
ously define a deficit in glucose transport 
under the conditions used by Montel-
Hagen et al. is to measure glucose flux 
with a nonmetabolizable analog, such 
as 3-O-methyl-D-glucose. This has not 
been done and thus at present there is 
no good evidence supporting the con-
tention of differential GLUT1 transport 
function during erythropoiesis.
Anthony Carruthers1,* and  
Richard J. Naftalin2
1Department of Biochemistry & Molecular 
Pharmacology, University of Massachusetts 
Medical School, Worcester, MA 01655, USA
2Department of Physiology, King’s College 
London, Waterloo Campus, London  
SE1 9HN, UK
*Correspondence:  
anthony.carruthers@umassmed.edu
DOI 10.1016/j.cell.2009.04.007
RefeRences
Carruthers, A. (1990). Physiol. Rev. 70, 
1135–1176.
Lowe, A.G., and Walmsley, A.R. (1986). Biochim. 
Biophys. Acta 857, 146–154.
Magnani, M., Stocchi, V., Dacha, M., and Fornaini, 
G. (1984). Biochim. Biophys. Acta 802, 346–351.
Magnani, M., Stocchi, V., Chiarantini, L., Serafini, 
G., Dacha, M., and Fornaini, G. (1986). J. Biol. 
Chem. 261, 8327–8333.
Mann, G.V., and Newton, P. (1975). Ann. N Y Acad. 
Sci. 258, 243–252.
Montel-Hagen, A., Kinet, S., Manel, N., Mon-
gellaz, C., Prohaska, R., Battini, J.L., Delaunay, 
J., Sitbon, M., and Taylor, N. (2008). Cell 132, Of all cells in the human body, erythro-
cytes express the highest level of the 
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expression is significantly upregulated 
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tel-Hagen et al., 2008a). This increase in 
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enhanced transport of L-dehydroascor-
bic acid (DHA), an oxidized intermedi-
ate of ascorbic acid (AA). Moreover, the 
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GLUT1 and its immediate reduction to 
AA constitutes a recycling system that 
has evolved in those mammals incapa-
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cies, which do not express GLUT1 and 
do not transport DHA. Thus, GLUT1 
expression by erythrocytes is specifi-
cally associated with increased DHA 
transport, whereas erythrocyte glucose 
uptake can be achieved using other 
GLUT transporters.
Glucose Transport in Human Blood 
Cell Progenitors
Carruthers and Naftalin question whether 
our measurements of glucose uptake 
(2-deoxyglucose, 2DG) in human eryth-
roid progenitors reflected decreased 
hexokinase activity rather than changes 
in actual transport. They base their argu-
ment on reference publications stating 
that hexokinase activity is high in eryth-
roblasts and is downregulated during 
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erythroid differentiation (Magnani et al., 
1984; Shinohara et al., 1985). However, 
this argument is spurious as we demon-
strated that glucose transport is already 
decreased in human immature eryth-
roblasts (Montel-Hagen et al., 2008a), 
where the hexokinase activity is very 
high (Magnani et al., 1984).
To further corroborate these data, we 
performed glucose uptake studies at 
early time points during erythroid differ-
entiation induced by recombinant eryth-
ropoietin (rEPO), when most cells are 
proerythroblasts or basophilic erythro-
blasts (for example, see Giarratana et al., 
2005; Figure 1A in Montel-Hagen et al., 
2008a). These immature erythroblasts 
have high hexokinase activity (Magnani 
et al., 1984; Shinohara et al., 1985), but 
we still performed transport assays on 
ice in order to minimize variations in 
enzymatic activity. As demonstrated in 
kinetic analyses, glucose transport in 
early erythroblasts (day 3 of differentia-
tion) was significantly decreased com-
pared to that in CD34+ hematopoietic 
progenitor cells, at time points as early 
as 1 s (see day 0 versus day 3 in Figure 
S1A of this Response, available online). 
We also addressed the relative contribu-
tions of glucose transport and hexoki-
nase activity by assessing the uptake of 
3-O-methylglucose (3-OMG) at an early 
time point of erythropoiesis (day 2 of 
differentiation). These uptake data (see 
Figure S1B here), using a nonmetaboliz-
able sugar analog, remain concordant 
with our previous experiments, thereby 
addressing the concern raised by Car-
ty in GLUT 
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ruthers and Naftalin. We can indeed 
assert that diminished glucose uptake 
during erythroid differentiation of CD34+ 
progenitor cells results from decreased 
glucose transport.
GLUT1-Mediated DHA Transport
We also demonstrated that GLUT1-
mediated DHA uptake in human red 
blood cells is not inhibited by glucose. 
Carruthers and Naftalin state that these 
results are inconsistent with previous 
findings, but they miss the key point 
that erythrocytes differ from other cell 
types. In nonerythroid cells, glucose 
indeed inhibits GLUT1-mediated DHA 
uptake, as shown by several groups (for 
example, see Rumsey et al., 1997; Mon-
tel-Hagen et al., 2008a). The sole publi-
cation that Carruthers and Naftalin cite 
to support their claim that glucose com-
petitively inhibits DHA uptake in eryth-
roid cells dates from 1975 and is quoted 
out of context. This elegant study, per-
formed years before GLUT1 was identi-
fied, used supraphysiological glucose 
concentrations to compete away DHA 
(Mann and Newton, 1975). This study 
has since been refuted by key publica-
tions demonstrating efficient and rapid 
DHA uptake by erythrocytes, even in 
the presence of a 50-fold molar excess 
of glucose (for example see Mendiratta 
et al., 1998). Our results (Montel-Hagen 
et al., 2008a and Figure S2 here) are in 
complete agreement with these latter 
studies. Thus, Carruthers and Naftalin 
seem to have overlooked published liter-
ature documenting differences between 
erythrocytes and nucleated cells. More-
over, a recent publication has shown that 
glucose does not affect DHA uptake in 
infant dog erythrocytes expressing high 
levels of GLUT1 (Ogawa, 2009). Thus, in 
erythrocytes, physiological glucose con-
centrations do not competitively inhibit 
GLUT1-mediated transport of DHA.
